
Cataract & Refractive
Latest News

EMA recommends approval of high-dose intravitreal aflibercept (Eylea®) 8mg for nAMD and macular oedema
By Hattie Hayes
Advertisement
Latest Videos


EMA recommends approval of high-dose intravitreal aflibercept (Eylea®) 8mg for nAMD and macular oedema